Saniona plans clinical trial application for pediatric epilepsy drug in December

Saniona announced its intention to file a clinical trial application for a new pediatric epilepsy drug in December, a step forward in its clinical pipeline. The company continues to focus on R&D of medicines modulating ion channels for neurological and psychiatric disorders.

Detected & updated continuously · Source: Nebula

Story subjects

Saniona

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula